FindTrial
Sign In

To determine the impact of latent tuberculosis on severity and outcomes in patients with suspected SARS-COV-19 infection

To determine the impact of latent tuberculosis on severity and outcomes in patients with suspected SARS-COV-19 infection - LATTICE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029203
Enrollment
300
Registered
2020-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Mantoux test and Interferon gamma release assay: Outcome evaluation in patients tested positive for latent tuberculosis Control Intervention1: Mantoux test and Interferon gamma release

Sponsors

AIIMS Research Section
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consecutively admitted COVID positive patients

Exclusion criteria

Exclusion criteria: Refusal of consent Active tuberculosis HIV Post 72 hours of admission or more than 7 days of symptom onset Any known immunodeficiency Pregnancy Malignancy Any other known systemic infection or disease altering T cell pathway

Design outcomes

Primary

MeasureTime frame
To determine prevalence of latent tuberculosis with respect to severity of illness amongst suspected SARS-COV-19 patientsTimepoint: At enrollment—

Secondary

MeasureTime frame
Co-relation between LTBI and various routine laboratory investigations done routinely as per hospital protocol (differential and absolute lymphocyte counts, monocyte counts, fibrinogen, D-dimer, ferritin)Timepoint: Till discharge from hospital, or death (whichever is earlier)—

Countries

India

Contacts

Public ContactDr Pavan Tiwari

AIIMS

pavan14281@gmail.com9968846678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026